Circulation Research, Vol 75, 454-461, Copyright © 1994 by American Heart Association

ARTICLES

Discrepancy between plasma and lung angiotensin-converting enzyme activity in experimental congestive heart failure. A novel aspect of endothelium dysfunction

H Huang, JF Arnal, C Llorens-Cortes, M Challah, F Alhenc-Gelas, P Corvol and JB Michel
Institut National de la Sante et de la Recherche Medicale, Paris, France.

The renin-angiotensin and cardiac natriuretic systems play an important role in the pathophysiology of congestive heart failure (CHF). The status of the membrane-bound pulmonary and renal activities of three ectoenzymes involved in the regulation of these systems-angiotensin- converting enzyme (ACE), neutral endopeptidase (NEP), and aminopeptidase A (APA)-was investigated in Wistar rats 3 months after induction of myocardial infarction (MI) and in sham-operated (control) rats. Plasma renin activity and ACE activity, plasma angiotensin II (Ang II) levels, and atrial natriuretic factor levels were simultaneously determined. The lung ACE activity was decreased in MI rats compared with control rats (P < .0001), and this decrease depended on the severity of the heart failure. In contrast, plasma ACE activity was increased in MI rats (P < .01), and this increase was also proportional to the severity of MI. Northern blot analysis showed that the lung ACE mRNA level in severe MI rats was half that of the control rats. Renal ACE activity of the MI rats was not affected, and neither renal or pulmonary NEP nor pulmonary APA activities were altered. Thus, lung ACE gene expression appears to be both organ- and enzyme- specifically regulated during CHF. Whereas plasma renin was increased in heart failure rats, plasma Ang II levels were not different from those of control rats. Thus, decreased lung ACE activity could possibly contribute to keeping plasma Ang II levels in the normal range. The decrease in lung ACE activity and mRNA levels, combined with increased plasma ACE activity, represents a novel aspect of endothelial dysfunction in CHF.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				R. Gaertner, D. Lepailleur-Enouf, W. Gonzalez, A. Nicoletti, C. Mandet, M. Philippe, J.-J. Mercadier, and J.-B. Michel Pulmonary endothelium as a site of synthesis and storage of interleukin-6 in experimental congestive heart failure Eur J Heart Fail, August 1, 2003; 5(4): 435 - 442. [Abstract] [Full Text] [PDF]

				R. Gaertner, F. Prunier, M. Philippe, L. Louedec, J.-J. Mercadier, and J.-B. Michel Scar and pulmonary expression and shedding of ACE in rat myocardial infarction Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H156 - H164. [Abstract] [Full Text] [PDF]

				M. E. Khalil, A. W. Basher, E. J. Brown Jr, and I. A. Alhaddad A remarkable medical story: benefits of angiotensin-converting enzyme inhibitors in cardiac patients J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1757 - 1764. [Abstract] [Full Text] [PDF]

				D. Lepailleur-Enouf, G. Egidy, M. Philippe, L. Louedec, J.-P. Henry, P. Mulder, and J.-B. Michel Pulmonary endothelinergic system in experimental congestive heart failure Cardiovasc Res, February 1, 2001; 49(2): 330 - 339. [Abstract] [Full Text] [PDF]

				A. B. Driss, C. Devaux, D. Henrion, M. Duriez, C. Thuillez, B. I. Levy, and J.-B. Michel Hemodynamic Stresses Induce Endothelial Dysfunction and Remodeling of Pulmonary Artery in Experimental Compensated Heart Failure Circulation, June 13, 2000; 101(23): 2764 - 2770. [Abstract] [Full Text] [PDF]

				S. J.L Bakker and R. O.B Gans About the role of shear stress in atherogenesis Cardiovasc Res, January 14, 2000; 45(2): 270 - 272. [Full Text] [PDF]

				W. Gosgnach, M. Challah, F. Coulet, J.-B. Michel, and T. Battle Shear stress induces angiotensin converting enzyme expression in cultured smooth muscle cells: possible involvement of bFGF Cardiovasc Res, January 14, 2000; 45(2): 486 - 492. [Abstract] [Full Text] [PDF]

				I. Espinasse, V. Iourgenko, C. Richer, M. Heimburger, N. Defer, M.-C. Bourin, F. Samson, E. Pussard, J.-F. Giudicelli, J.-B. Michel, et al. Decreased type VI adenylyl cyclase mRNA concentration and Mg2+-dependent adenylyl cyclase activities and unchanged type V adenylyl cyclase mRNA concentration and Mn2+-dependent adenylyl cyclase activities in the left ventricle of rats with myocardial infarction and longstanding heart failure Cardiovasc Res, April 1, 1999; 42(1): 87 - 98. [Abstract] [Full Text] [PDF]

				C. Marie, C. Mossiat, C. Gros, J.-C. Schwartz, J.-M. Lecomte, and J. Bralet Effect of long-term therapy with fasidotril, a mixed inhibitor of neprilysin and angiotensin-converting enzyme (ACE), on survival of rats after myocardial infarction Cardiovasc Res, March 1, 1999; 41(3): 544 - 553. [Abstract] [Full Text] [PDF]

				M. Pfeifer, G. Bruckschlegel, S. R Holmer, M. Paul, A.J.G. Riegger, and H. Schunkert Reciprocal regulation of pulmonary and cardiac angiotensin-converting enzyme in rats with severe left ventricular hypertrophy Cardiovasc Res, April 1, 1998; 38(1): 125 - 132. [Abstract] [Full Text] [PDF]

				M. Challah, S. Nadaud, M. Philippe, T. Battle, F. Soubrier, B. Corman, and J. B. Michel Circulating and cellular markers of endothelial dysfunction with aging in rats Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1941 - H1948. [Abstract] [Full Text] [PDF]

				A. Luchner, T. L. Stevens, D. D. Borgeson, M. M. Redfield, J. E. Bailey, S. M. Sandberg, D. M. Heublein, and J. C. Burnett Angiotensin II in the Evolution of Experimental Heart Failure Hypertension, September 1, 1996; 28(3): 472 - 477. [Abstract] [Full Text]

				F. Pieruzzi, Z. A. Abassi, and H. R. Keiser Expression of Renin-Angiotensin System Components in the Heart, Kidneys, and Lungs of Rats With Experimental Heart Failure Circulation, November 15, 1995; 92(10): 3105 - 3112. [Abstract] [Full Text]

				Z. A. Abassi, S. Kotob, E. Golomb, F. Pieruzzi, and H. R. Keiser Pulmonary and Renal Neutral Endopeptidase EC 3.4.24.11 in Rats With Experimental Heart Failure Hypertension, June 1, 1995; 25(6): 1178 - 1184. [Abstract] [Full Text]